Iatrogenic risk is a necessary component of any curative medical inter
vention in medicine. By contrast, its existence is often ignored in pu
blic health programmes. The example of breast cancer screening by mean
s of mammography is studied here to describe the type and importance o
f risks linked to the screening examination itself, but also to the en
suing complementary procedures in order to evaluate the global impact
on women's health in the general population. Methods for risk evaluati
on and the few data available in the literature are reviewed. The aim
of the present article is to ensure the respect of principles of ethic
s in the health interventions directed towards populations considered
a priori as being healthy, and to put the case for high quality screen
ing.